European Commission unveils the EU-US Privacy Shield

Life Sciences & Healthcare Update & Alert

Life Sciences & Healthcare Update & Alert

Patents Court finds Herceptin patent invalid

The Patents Court has found a patent relating to Herceptin invalid on the grounds of obviousness.

Court of Appeal overturns declarations of non-infringement in relation to Alimta

The Court of Appeal has overturned Arnold J's decision granting declarations of non-infringement in respect of Alimta.

Court of Appeal allows ConvaTec’s appeal leaving Smith & Nephew to lick its wounds

The Court of Appeal has overturned Birss J’s decision concerning construction of a numerical range

UPC Preparatory Committee clarification on effect of opt-out

The UPC Preparatory Committee has provided guidance on the opt-out and transitional period in relation to standard European patents.

EPO endorses True Top 4 renewal fees proposal

The EPO has endorsed the True Top 4 proposal for unitary patent renewal fees.

Patents Court decision on Synthon’s challenge to Copaxone patents

The Patents Court has considered the validity of two Copaxone-related patents.

Patents Court declines to make reference to CJEU on the SPC Regulation

The Patents Court has refused to make a reference to the CJEU in relation to the SPC Regulation.

Court of Appeal construes second medical use claims

The Court of Appeal has construed second medical use claims in the context of a dispute relating to pregabalin.

Patent Court invalidates rivastigmine patch patent

The Patents Court has decided that Novartis' patent for rivastigmine patches is invalid for added matter and obviousness.

Court of Appeal upholds £27million damages award under cross-undertaking

Court of Appeal upholds damages award of £27million for losses suffered during period of interim injunction.

ChinaBio Partnering Forum 2015: Investment Opportunities in Life Sciences

Andrew Shindler reports on the recent ChinaBio Partnering Forum in Shanghai.

UK IPO guidance on inventions involving human embryonic stem cells

The UK IPO has issued updated guidance on inventions involving human embryonic stem cells.

本网站使用Cookie来增强您的体验并帮助我们改善网站。请参阅我们的隐私政策以获取更多信息。如果您继续浏览网站而不更改设置,我们将假设您愿意收到这些Cookie。您可以随时更改Cookie设置

有关我们使用哪些类型Cookie的更多信息,请参阅我们的Cookie使用政策